Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: A cohort study

The Lancet Oncology

Volumn 11, Issue 9, 2010, Pages 827-834

  Engels, Eric A ^a   Cho, Eo Rin ^b   Jee, Sun Ha ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Korea University College of Medicine   (South Korea)

^c Institute for Health Promotion Seoul   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HEPATITIS B; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MONOCYTIC LEUKEMIA; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH KOREA; T CELL LYMPHOMA; COMPLICATION; INCIDENCE; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; RISK FACTOR; VIROLOGY;

ADULT; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS;

EID: 77956189884     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70167-4     Document Type: Article

References (37)

1. Liaw YF, Chu CM Hepatitis B virus infection. Lancet 2009, 373:582-592.
2. Parkin DM The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-3044.
3. Kim JH, Bang YJ, Park BJ, et al. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002, 93:471-477.
4. Park SC, Jeong SH, Kim J, et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol 2008, 80:960-966.
5. Chen MH, Hsiao LT, Chiou TJ, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008, 87:475-480.
6. Wang F, Xu RH, Han B, et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007, 109:1360-1364.
7. Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica 2006, 91:554-557.
8. Lim ST, Fei G, Quek R, et al. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007, 79:132-137.
9. Kuniyoshi M, Nakamuta M, Sakai H, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001, 16:215-219.
10. Anderson LA, Pfeiffer R, Warren JL, et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008, 17:3069-3075.
11. Yood M Ulcickas, Quesenberry CP, Guo D, et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007, 46:107-112.
12. Anderson LA, Engels EA Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship?. Int J Cancer 2008, 122:x-xii.
13. Viswanatha DS, Dogan A Hepatitis C virus and lymphoma. J Clin Pathol 2007, 60:1378-1383.
14. de Sanjose S, Benavente Y, Vajdic CM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008, 6:451-458.
15. Dal Maso L, Franceschi S Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006, 15:2078-2085.
16. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009, 10:321-322.
17. Ahn YO Strategy for vaccination against hepatitis B in areas with high endemicity: focus on Korea. Gut 1996, 38(suppl 2):S63-S66.
18. Jee SH, Ohrr H, Sull JW, Samet JM Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004, 96:1851-1856.
19. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002, 17:457-462.
20. Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS Smoking and cancer risk in Korean men and women. Cancer Causes Control 2004, 15:341-348.
21. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000, 15:1356-1361.
22. Nath A, Agarwal R, Malhotra P, Varma S Prevalence of hepatitis B virus infection in non-Hodgkin's lymphoma. A systematic review and meta-analysis. Intern Med J 2009, published online Oct 7. 10.1111/j.1445-5994.2009.02060.x.
23. Amin J, Dore GJ, O'Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006, 45:197-203.
24. Pontisso P, Vidalino L, Quarta S, Gatta A Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev 2008, 8:13-17.
25. Morton LM, Wang SS, Cozen W, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008, 112:5150-5160.
26. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007, 297:2010-2017.
27. Fujimoto K, Endo T, Nishio M, et al. Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier. Int J Hematol 2009, 90:601-604.
28. Han SH Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004, 8:403-418.
29. Lee JH, Lee EJ, Kim SS, Nam JG, Whang J, Kee MK Epidemiological characteristics of HIV-infected women in the Republic of Korea: a low HIV prevalence country. J Public Health Policy 2009, 30:342-355.
30. Shin HR Epidemiology of hepatitis C virus in Korea. Intervirology 2006, 49:18-22.
31. Loomba R, Rowley A, Wesley R, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008, 148:519-528.
32. Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009, 27:605-611.
33. Palmore TN, Shah NL, Loomba R, et al. Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. Clin Gastroenterol Hepatol 2009, 7:1130-1137.
34. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007, 45:1056-1075.
35. Hennekens CH, Buring JE Epidemiology in medicine 1987, Little, Brown, Boston, MA, USA.
36. Chang MH, You SL, Chen CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009, 101:1348-1355.
37. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther 2005, 21:653-662.